Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Clinical trials have demonstrated that tirzepatide produces substantial weight loss, with patients without diabetes achieving approximately 15-20% body weight reduction at the highest doses in the SURMOUNT trialssignificantly greater than results observed with selective GLP-1 receptor agonists
How the drugs work These lapses matter because tirzepatide and semaglutide, originally developed for type-2 diabetes, influence appetite by mimicking gut hormones
Therefore, avoid skipping meals and monitor your glucose levels regularly
While Zepbound (tirzepatide) demonstrates significant efficacy in clinical trials, with approximately 91% of participants achieving at least 5% body weight reduction at the highest dose, individual responses vary considerably
US$ 23.97
US$ 23.23
US$ 20.63
US$ 22.03
US$ 27.18
US$ 27.37
US$ 25.93
US$ 24.92
US$ 25.42
US$ 27.49
